|

CDX-622 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Celldex Therapeutics1

Indications

  • Mild to Moderate Asthma1
  • Asthma1

Kansas City, Kansas1 trial

A Study of CDX-622 in Participants With Mild to Moderate Asthma

The University of Kansas Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.